The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?
about
Adjunctive antioxidants for bipolar disorderDevelopment and Evaluation of a Smartphone-Based Measure of Social Rhythms for Bipolar Disorder.Is seasonal affective disorder a bipolar variant?Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcomeThe role of BDNF as a mediator of neuroplasticity in bipolar disorder.Inter-episode affective intensity and instability: predictors of depression and functional impairment in bipolar disorder.An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trialThe Burden of Repeated Mood Episodes in Bipolar I Disorder: Results From the National Epidemiological Survey on Alcohol and Related Conditions.Development of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder.Where should bipolar disorder appear in the meta-structure?Therapeutic use of omega-3 fatty acids in bipolar disorder.Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.Emerging drugs for bipolar depression: an update.Simplifying profiles of comorbidity in bipolar disorder.Self-monitoring practices, attitudes, and needs of individuals with bipolar disorder: implications for the design of technologies to manage mental health.Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression.Bipolar patients referred to specialized services of care: Not resistant but impaired by sub-syndromal symptoms. Results from the FACE-BD cohort.Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder.Joint analysis of cognitive and circadian variation in Schizophrenia and Bipolar I Disorder.Omega-3 fatty acids alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration.Daytime sleepiness, sleep disturbance and functioning impairment in bipolar disorder.Bipolar disorder in women.Feeling out of control: a qualitative analysis of the impact of bipolar disorder.An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.Damage-associated molecular patterns and immune activation in bipolar disorder.An adjunct exercise program for serious mental illness: who chooses to participate and is it feasible?Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex.Management of inter-episodic periods in patients with bipolar disorder
P2860
Q24198987-A365387E-8AF2-475C-920F-13848CC49D2FQ33449462-6FBE24A5-F535-4EDF-A2E6-F093E0878284Q33867761-6123F302-0936-49A2-B957-9FCF2220CA66Q34034971-F60B5146-4865-406E-B75C-30BEE05561B0Q34497541-230CE7B5-1AA5-412A-8CA7-6955451B0C7EQ34623516-4136C46F-D9BF-409A-AD7E-E843AB74C775Q35690464-02A794AA-B533-4F1D-95B8-9FCCFBA1A8F0Q36522713-5046BF34-5302-40A2-AD87-BBC52F568C00Q36860514-C98AE365-6C66-4FE9-BC54-FFA08E38590DQ37606631-0D726D19-BDAB-43DC-ABD9-5EA2D6B7A14FQ37896631-16B87A12-CAAA-40AF-853D-66AE9BD4E510Q38125218-4DB3157A-6BBC-4CD6-967C-019A5BB1B8C3Q38176400-30D5F8B0-76CC-47D6-86D1-ADA6990F8E06Q38732227-54E09F79-403D-4F1F-BA50-254491BE4CABQ39971448-891B5A5A-AA95-4BAC-B137-F4FD416C8ECFQ40294491-174D1AA4-2BF9-4D62-812C-0DFA364FE82BQ40921191-91AFF5DA-90B8-4706-A668-6C58D117DD74Q42625614-6FBAE6C8-2FB4-45C3-A261-5A8EB3E9D613Q47572410-7A2F63B8-53B8-4E1B-A189-B5081CC3C45CQ47813961-489DB605-B343-4CA9-B10C-2354F604EF6DQ48186513-EA8D8304-142A-42AB-8F60-C4A7ADFCB541Q48191720-EA46E37E-560A-464A-BD32-42922E711E7BQ48548437-D65F7F14-BB31-44D4-A8CA-07C1D4767D66Q48908840-A167BAB3-D697-4826-B70F-CC357282C47FQ50279906-967B879F-85F0-433C-9597-CE63BC60B7AFQ50739444-DF9AC855-D7F9-4896-AA71-3D4CE90F4337Q53070945-D3DF0D68-B65D-4EEA-883C-7D3F1FA0611BQ57612238-E1E4F994-9672-4EBF-93A7-E67E4E355444
P2860
The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
The phenomenology of bipolar d ...... etermines long-term prognosis?
@ast
The phenomenology of bipolar d ...... etermines long-term prognosis?
@en
type
label
The phenomenology of bipolar d ...... etermines long-term prognosis?
@ast
The phenomenology of bipolar d ...... etermines long-term prognosis?
@en
prefLabel
The phenomenology of bipolar d ...... etermines long-term prognosis?
@ast
The phenomenology of bipolar d ...... etermines long-term prognosis?
@en
P2093
P2860
P356
P1476
The phenomenology of bipolar d ...... etermines long-term prognosis?
@en
P2093
David J Kupfer
Ellen Frank
Isabella Soreca
P2860
P356
10.1002/DA.20521
P577
2009-01-01T00:00:00Z